The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
Open accessAbstract
The purpose of this work is to review the published studies on the mechanisms of action and resistance of 5-fluorouracil. The review is divided into three main sections: mechanisms of anti-tumor action, studies of the resistance to the drug, and procedures for the identification of new genes involved in resistance with microarray techniques. The details of the induction and reversal of the drug resistance are also described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., Focan, C., Chollet, P., Llory, J. F., Letourneau, Y., Coudert, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.136 · Cited by 1,403
Johnston, P. G., Lenz, H.-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., & Leichman, L. (1995) · PubMed · Cited by 672
Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast
Giaever, G., Flaherty, P., Kumm, J., Proctor, M., Nislow, C., Jaramillo, D. F., Chu, A. M., Jordan, M. I., Arkin, A. P., & Davis, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307490100 · Cited by 504
Thymidylate synthetase - a target enzyme in cancer chemotherapy
Danenberg, P. V. (1977) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(77)90001-4 · Cited by 502
Lum, P. Y., Armour, C. D., Stepaniants, S. B., Cavet, G., Wolf, M. K., Butler, J. S., Hinshaw, J. C., Garnier, P., Prestwich, G. D., Leonardson, A., et al. (2004) · Cell · doi:10.1016/s0092-8674(03)01035-3 · Cited by 481
Metabolism and mechanism of action of 5-fluorouracil
Parker, W. B., & Cheng, Y. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90056-8 · Cited by 451
Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 422
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
Peters, G. J., Backus, H. H. J., Freemantle, S., van Triest, B., Codacci-Pisanelli, G., van der Wilt, C. L., Smid, K., Lunec, J., Calvert, A. H., Marsh, S., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00082-0 · Cited by 420
5-Fluorouracil: Forty-Plus and Still Ticking. A Review of its Preclinical and Clinical Development
Grem, J. L. (2000) · Investigational New Drugs · doi:10.1023/a:1006416410198 · Cited by 417
Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin
Lechner, M., Lirk, P., & Rieder, J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.004 · Cited by 410
Shirasaka, T., Nakano, K., Takechi, T., Satake, H., Uchida, J., Fujioka, A., Saitô, H., Okabe, H., Oyama, K., Takeda, S., et al. (1996) · PubMed · Cited by 370
Etienne, M. C., Chéradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renée, N., Schneider, M., Thyss, A., Demard, F., & Milano, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1663 · Cited by 281
Arnold, C. N., Goel, A., & Boland, C. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11176 · Cited by 280
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity
Milano, G., Etienne, M. C., Pierrefite, V, Barberi-Heyob, M., Deporte-Fety, R., & Renée, N. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690098 · Cited by 275
Noordhuis, P., Holwerda, U., Van der Wilt, C. L., Van Groeningen, C. J., Smid, K., Meijer, S., Pinedo, H. M., & Peters, G. J. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh264 · Cited by 264
Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C., & Wataya, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47554-0 · Cited by 252
Pratt, S., Shepard, R. L., Kandasamy, R. A., Johnston, P. A., Perry, W., & Dantzig, A. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0291 · Cited by 245
Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.
Swain, S. M., Lippman, M. E., Egan, E. F., Drake, J. C., Steinberg, S. M., & Allegra, C. J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.890 · Cited by 241
De Angelis, P. M., Svendsrud, D. H., Kravik, K. L., & Stokke, T. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-20 · Cited by 233
Raida, M., Schwabe, W., Häusler, P., Kuilenburg, A. B. P., Gennip, A. H., Behnke, D., & Höffken, K. (2001) · PubMed · Cited by 231
Violette, S., Poulain, L., Dussaulx, E., Pepin, D., Faussat, A., Chambaz, J., Lacorte, J., Staedel, C., & Lesuffleur, T. (2002) · International Journal of Cancer · doi:10.1002/ijc.10146 · Cited by 213
Rutman, R. J., CANTAROW, A., & Paschkis, K. E. (1954) · PubMed · Cited by 196
Hwang, J.-T., Ha, J., & Park, O. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.143 · Cited by 191
Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
Chu, E., Zinn, S., Boarman, D., & Allegra, C. J. (1990) · PubMed · Cited by 180
Shi, X., Liu, S., Kleeff, J., Friess, H., & Büchler, M. W. (2002) · Oncology · doi:10.1159/000065068 · Cited by 177
A New Polymorph of 5-Fluorouracil Found Following Computational Crystal Structure Predictions
Hulme, A. T., Price, S. L., & Tocher, D. A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044336a · Cited by 177
Shin, Y.-K., Yoo, B. C., Chang, H. J., Jeon, E., Hong, S.-H., Jung, M.-S., Lim, S.-J., & Park, J.-G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3300 · Cited by 163
5‐FLUOROURACIL: A PHARMACOLOGICAL PARADIGM IN THE USE OF CYTOTOXICS
Thomas, D. M., & Zalcberg, J. R. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02339.x · Cited by 160
van Triest, B., Pinedo, H. M., van Hensbergen, Y., Smid, K., Telleman, F., Schoenmakers, P. S., van der Wilt, C. L., van Laar, J. A. M., Noordhuis, P., Jansen, G., et al. (1999) · PubMed · Cited by 145
Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
Spears, C. P., Gustavsson, B. G., Berne, M., Frösing, R., Bernstein, L., & Hayes, A. A. (1988) · PubMed · Cited by 138
Drug resistance to 5-FU linked to reactive oxygen species modulator 1
竹門, 康., Chung, Y. M., Kim, J. J., Chung, J. S., Kim, B. S., Kim, H. J., Kim, J. S., & Yoo, Y. D. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.088 · Cited by 137
Tajima, A., Heß, M., Cabrera, B. L., Kolodner, R. D., & Carethers, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.10.001 · Cited by 136
An, Q., Robins, P., Lindahl, T., & Barnes, D. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2960 · Cited by 134
Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells
Wang, W., Cassidy, J., O’Brien, V., Ryan, K. M., & Collie-Duguid, E. S. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0970 · Cited by 120
ffski, P. S. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200402000-00001 · Cited by 114
Dolnick, B. J., & Cheng, Y. C. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34838-x · Cited by 110
Peták, I., Tillman, D. M., & Houghton, J. A. (2000) · PubMed · Cited by 106
Angelis, P. D., Fjell, B., Kravik, K., Haug, T., Tunheim, S. H., Reichelt, W. H., Beigi, M., Clausen, O. P. F., Galteland, E., & Stokke, T. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.5.1279 · Cited by 99
5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs
Fang, F., Hoskins, J. W., & Butler, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10766-10776.2004 · Cited by 95
Houghton, J. A., Tillman, D. M., & Harwood, F. G. (1995) · PubMed · Cited by 93
Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast
Gustavsson, M., & Ronne, H. (2008) · RNA · doi:10.1261/rna.966208 · Cited by 92
Bruni, P., Minopoli, G., Brancaccio, T., Napolitano, M., Faraonio, R., Zambrano, N., Hansen, U. M., & Russo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205227200 · Cited by 91
Liu, R., Page, C., Beidler, D. R., Wicha, M. S., & Núñez, G. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65505-8 · Cited by 90
Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo
Zhao, X., & Yu, Y.-T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1084 · Cited by 89
Zhu, H., Guo, W., Zhang, L., Davis, J. J., Teraishi, F., Wu, S., Cao, X. X., Daniel, J. M., Smythe, W. R., & Fang, B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0162 · Cited by 74
Interactions of transfer RNA pseudouridine synthases with RNAs substituted with fluorouracil
Samuelsson, T. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.22.6139 · Cited by 71
Radparvar, S., Houghton, P. J., & Houghton, J. A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90046-4 · Cited by 69
Aherne, G. W., Hardcastle, A., Raynaud, F. I., & Jackman, A. L. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00035-4 · Cited by 65
Cell cycle perturbation and acquired 5-fluorouracil chemoresistance.
Guo, X., Goessl, E., Jin, G., Collie-Duguid, E. S. R., Cassidy, J., Wang, W., & O’Brien, V. (2008) · PubMed · Cited by 65
Houghton, J. A., & Houghton, P. J. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90013-5 · Cited by 62
Tsujie, M., Nakamori, S., Nakahira, S., Takahashi, Y. K., Hayashi, N., Okami, J., Nagano, H., Dono, K., Umeshita, K., Sakon, M., et al. (2007) · PubMed · Cited by 60
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts
Ooyama, A., Oka, T., Zhao, H., Yamamoto, M., Akiyama, S., & Fukushima, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.008 · Cited by 60
Enhancement of 5-fluorouracil's anticancer activity by dipyridamole
Grem, J. L., & Fischer, P. H. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90084-3 · Cited by 57
Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cells
Priest, D. G., Ledford, B. E., & Doig, M. T. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90607-3 · Cited by 55
Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase
Peña, M. M. O., Xing, Y., Koli, S., & Berger, F. G. (2006) · Biochemical Journal · doi:10.1042/bj20051479 · Cited by 54
Brenes, O., Vargas, F. A., Gätjens-Boniche, O., & Díaz, C. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.02.007 · Cited by 52
Shi, L.-X., Ma, R., Lu, R., Xu, Q., Zhu, Z., Wang, L., Zhou, C., Li, X., Zhang, H., & Yao, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.033 · Cited by 52
Zhu, H., Zhang, L., Huang, X., Davis, J. J., Jacob, D., Teraishi, F., Chiao, P. J., & Fang, B. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.007 · Cited by 52
Structural Determinants for the Intracellular Degradation of Human Thymidylate Synthase
Forsthoefel, A. M., Peña, M. M. O., Xing, Y., Rafique, Z., & Berger, F. G. (2004) · Biochemistry · doi:10.1021/bi035894p · Cited by 49
Park, J., Yoon, S. Y., Kim, J., Yeom, Y.-I., Kim, Y. S., & Kim, N.-S. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.04.012 · Cited by 48
Webley, S. D., Hardcastle, A., Ladner, R. D., Jackman, A. L., & Aherne, G. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1358 · Cited by 46
Dissecting progressive stages of 5‐fluorouracil resistance in vitro using RNA expression profiling
Schmidt, W. M., Kalipciyan, M., Dornstauder, E., Rizovski, B., Steger, G. G., Sedivy, R., Mueller, M. W., & Mader, R. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20401 · Cited by 46
Wada, H., Nagano, H., Yamamoto, H., Arai, I., Ôta, H., Nakamura, M., Damdinsuren, B., Noda, T., Marubashi, S., Miyamoto, A., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.801 · Cited by 45
Wang, W., McLeod, H. L., Cassidy, J., & Collie-Duguid, E. S. R. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0384-5 · Cited by 45
RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p
Hoskins, J. W., & Butler, J. S. (2008) · Genetics · doi:10.1534/genetics.107.082727 · Cited by 45
Longley, D. B., Latif, T., Boyer, J. L., ALLEN, W., Maxwell, P., & Johnston, P. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)70019-0 · Cited by 44
Hoskins, J. W., & Butler, J. S. (2007) · Yeast · doi:10.1002/yea.1516 · Cited by 42
Newby, Z. E. R., Lee, T. T., Morse, R. J., Liu, Y., Liu, L., Venkatraman, P., Santi, D. V., Finer-Moore, J. S., & Stroud, R. M. (2006) · Biochemistry · doi:10.1021/bi060152s · Cited by 41
Advances in Chemotherapy against Advanced or Metastatic Colorectal Cancer
Omura, K. (2008) · Digestion · doi:10.1159/000111483 · Cited by 39
Thymidyl biosynthesis enzymes as antibiotic targets
Chernyshev, A., Fleischmann, T., & Kohen, A. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0763-1 · Cited by 38
Structure-based studies on species-specific inhibition of thymidylate synthase
Costi, M. P., Tondi, D., Rinaldi, M., Barlocco, D., Pecorari, P., Soragni, F., Venturelli, A., & Stroud, R. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00083-2 · Cited by 37
Konishi, T., Sasaki, S., Watanabe, T., Kitayama, J., & Nagawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1209342 · Cited by 34
Longley, D. B., Latif, T., Boyer, J., et al. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00119-2 · Cited by 34
Kim, H. K., Choi, I. J., Kim, H. S., Kim, J. H., Kim, E. S., Park, I. S., Chun, J. H., Kim, I.-H., Kim, I.-J., Kang, H. C., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.109 · Cited by 31
Genome‐wide screening of loci associated with drug resistance to 5‐fluorouracil‐based drugs
Ooyama, A., Okayama, Y., Takechi, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00424.x · Cited by 29
Synthesis and Bioevaluation of 5-Fluorouracil Derivatives
Tian, Z., Du, G., Xie, S., Zhao, J., Gao, W., & Wang, C. (2007) · Molecules · doi:10.3390/12112450 · Cited by 29
Nord, S., Alnæs, G. I. G., Hihn, B., Lingjærde, O. C., Liestøl, K., Tsalenko, A., Sørlie, T., Lønning, P. E., Børresen‐Dale, A., & Kristensen, V. N. (2008) · International Journal of Cancer · doi:10.1002/ijc.23541 · Cited by 25
Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil
Tseng, Y.-S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00225-8 · Cited by 25
Fanciullino, R., Giacometti, S., Mercier, C., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603970 · Cited by 25
Zhang, F., Yao, X., Tian, X., & Tu, Y. (2006) · Molecules · doi:10.3390/11110849 · Cited by 20
Szőke, D., Györffy, A., Surowiak, P., Tulassay, Z., Dietel, M., & Győrffy, B. (2007) · Oncology Research and Treatment · doi:10.1159/000104490 · Cited by 15
Yu, Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1979 · Cited by 14
Sakurai, Y., Sakamoto, K., Sugimoto, Y., Yoshida, I., Masui, T., Tonomura, S., Inaba, K., Shoji, M., Nakamura, Y., Uyama, I., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00200.x · Cited by 11
Cited by
Drug resistance in cancer: An overview
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014) · Cancers · doi:10.3390/cancers6031769 · Cited by 2,463
Blondy, S., David, V., Verdier, M., Mathonnet, M., Perraud, A., & Christou, N. (2020) · Cancer Science · doi:10.1111/cas.14532 · Cited by 507
Liu, Y., Zheng, C., Huang, Y., He, M., Xu, W. W., & Li, B. (2021) · MedComm · doi:10.1002/mco2.55 · Cited by 387
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
Cho, Y.-H., Ro, E. J., Yoon, J.-S., Mizutani, T., Kang, D.-W., Park, J.-C., Il Kim, T., Clevers, H., & Choi, K.-Y. (2020) · Nature Communications · doi:10.1038/s41467-020-19173-2 · Cited by 336
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Ramos, A., Sadeghi, S., & Tabatabaeian, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179451 · Cited by 289
Metadata
- Authors
- Zhang, N., Yin, Y., Xu, S.-J., & Chen, W.-S.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2008-08-05
- Volume
- 13
- Issue
- 8
- Pages
- 1551-1569
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2130392703
- Cited by
- 771
- References
- 89
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.